Hopital neurologique Pierre Wertheimer - CHU Lyon

Bron 69677

0 studies enrolling now · 2 studies all time

What they study most

LGI1 Autoimmune Encephalitis, NMDAR Autoimmune Encephalitis, Progressive Multiple Sclerosis (PMS)

Studies at this site

• A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis — Running, not enrolling
• A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis — Running, not enrolling